I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Anlotinib plus icotinib as a potential treatment option for..:
Linlin Zhang
;
Liuchun Wang
;
Jingya Wang
...
https://doi.org/10.1186/s12943-023-01823-w. , 2023
Link:
https://doi.org/10.1186/s12943-023-01823-w
RT Journal T1
Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7412f8ddf49f4c39a5829eae389056f1&Exemplar=1&LAN=DE A1 Linlin Zhang A1 Liuchun Wang A1 Jingya Wang A1 Jinliang Chen A1 Zhaoting Meng A1 Zhujun Liu A1 Xiangli Jiang A1 Xinyue Wang A1 Chun Huang A1 Peng Chen A1 Yan Liang A1 Richeng Jiang A1 Jing Wang A1 Diansheng Zhong A1 Yanhong Shang A1 Yan Zhang A1 Cuiying Zhang A1 Dingzhi Huang PB BMC YR 2023 K1 Non-small-cell lung cancer K1 ErbB receptors K1 Prognosis K1 Safety K1 Anlotinib K1 Icotinib K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s12943-023-01823-w LK http://dx.doi.org/https://doi.org/10.1186/s12943-023-01823-w DO https://doi.org/10.1186/s12943-023-01823-w SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)